Skip to main content

Table 1 Clinical characteristics female subjects in study cohorts. Numbers indicate average and standard deviation for each trait

From: Identification of female-specific genetic variants for metabolic syndrome and its component traits to improve the prediction of metabolic syndrome in females

  KARE Rural1816 Rural3667 HEXA
aN (MetS/contol) 4659 (1211/639) 957 (404/21) 2265 (424/330) 2051 (237/702)
Age (years) 52.6 (±9.0) 60.8 (±6.4) 58.8 (±10.0) 51.6 (±7.7)
Waist circumference (cm) 81.6 (±10.1) 85.1 (±8.5) 82.1 (±8.9) 79.2 (±8.4)
WHR 0.86 (±0.36) 0.89 (±0.06) 0.89 (±0.07) 0.84 (±0.06)
BMI (kg/m2) 24.9 (±3.26) 25.2 (±3.4) 24.0 (±3.1) 23.7 (±3.0)
FPG (mg/dL) 82.3 (±25.5) 114.8 (±43.3) 93.0 (±9.3) 91.3 (±26.1)
HDLC (mg/dL) 45.6 (±10.1) 45.4 (±10.6) 46.3 (±10.4) 57.6 (±13.3)
LDLC (mg/dL) 114.4 (±35.4) 133.3 (±35.2) 129.0 (±31.9) 120.4 (±31.5)
TG (mg/dL) 149.0 (±88.9) 169.2 (±110.2) 129.1 (±70.9) 106.6 (±69.4)
TCHL (mg/dL) 191.4 (±35.7) 210.9 (±41.4) 200.6 (±35.7) 198.8 (±35.1)
SBP (mmHg) 124.2 (±20.0) 133.0 (±18.2) 114.7 (±11.7) 119.1 (±14.4)
DBP (mmHg) 81.3 (±11.9) 83.4 (±11.2) 74.4 (±7.5) 75.1 (±9.8)
ALT (IU/L) 23.3 (±17.3) 25.9 (±19.5) 21.1 (±11.4) 20.4 (±12.9)
AST (IU/L) 27.2 (±13.6) 28.2 (±21.2) 25.0 (±8.6) 22.6 (±9.2)
GTP (IU/L) 19.3 (±24.0) 27.7 (±50.6) 17.9 (±16.9) 21.0 (±17.6)
Albumin (g/dL) 4.2 (±0.3) 4.6 (±0.3) 4.4 (±0.2) 4.6 (±0.3)
  1. aThese numbers indicate the number of subjects used for the association analysis
  2. WHR waist-hip ration, BMI body mass index, FPG fasting plasma glucose, HDLC high density lipoprotein cholesterol, LDLC low density lipoprotein cholesterol, TG triglyceride, TCHL total cholesterol, SBP systolic blood presure, DBP diastolic blood presure, ALT aspartate transaminase, AST alanine transaminase, GTP Glutamyl Transpeptidase